Insulin-Like Growth Factor-1 and Its Binding Proteins

Endocrinology: Adult and Pediatric, Sixth Edition

Volumn 1, Issue , 2010, Pages 454-478

  Clemmons, David R ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85028501876     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-5583-9.00024-1     Document Type: Chapter

References (305)

1. WD Salmon Jr and WH Daughaday (1957) A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro. J Lab Clin Med 49 825.
2. E Schoenle, J Zapf, RE Humbel, et al. (1982) Insulin-like growth factor I stimulates growth in hypophysectomized rats. Nature 296 252.
3. LJ Murphy and HG Freisen (1988) Differential effects of estrogen and growth hormone on uterine and hepatic insulin like growth factor-I gene expression in ovariectomized and hypophysectomized rat. Endocrinology 122 325.
4. EC Holt, JJ Van Wyk and PK Lund (1988) Tissue and development specific regulation of a complex family of insulin-like growth factor I messenger ribonucleic acids. Mol Endocrinol 2 1077.
5. B Carlsson, L Carlsson and H Billig (1989) Estrus cycle dependent covariation of the insulin-like growth factor I (IGF-I) messenger ribonucleic acid and protein in rat ovary. Mol Cell Endocrinol 64 271.
6. P Rotwein, DP Bichell and K Kikuchi (1993) Multifactorial regulation of IGF-I gene expression. Mol Reprod Dev 35 358.
7. JE Hepler, JJ VanWyk and PK Lund (1990) Different half-lives of insulin-like growth factor-I mRNA that differ in length of 3′ untranslated sequence. Endocrinology 127 155.
8. ML Bayne, J Applebaum, GG Chicchi, et al. (1990) The roles of tyrosines 24, 31, and 60 in the high-affinity binding of insulin-like growth factor-I to the type 1 insulin-like growth factor receptor. J Biol Chem 265 15648.
9. ML Bayne, J Applebaum, D Underwood, et al. (1989) The C region of human insulin-like growth factor (IGF) I is required for high-affinity binding to the type I IGF receptor. J Biol Chem 264 11004.
10. FF Vajdos, M Ultsch, ML Schaffer, et al. (2001) Crystal structure of human insulin-like growth factor-1: detergent binding inhibits binding protein interactions. Biochem 40 11022.
11. W Zeslawski, HG Beisel, M Kamionka, et al. (2001) The interaction of insulin-like growth factor-I with the N-terminal domain of IGFBP-5. EMBO J 20 3638.
12. ML Shaffer, K Deshayes, G Nakamura, et al. (2003) Complex with a phage display-derived peptide provides insight into the function of insulin-like growth factor I. Biochem 42 9324.
13. L Gauguin, C. Delaine Ca, CL Alvino, et al. (2008) Alanine scanning of a putative receptor binding surface of insulin-like growth factor-I. J Biol Chem 283 20821.
14. DR Clemmons, MH Dehoff, WH Busby, et al. (1992) Competition for binding to insulin-like growth factor (IGF) binding protein-2, 3, 4, and 5 by the IGFs and IGF analogs. Endocrinology 131 890.
15. I Siwanowicz, GM Popowicz, M Wisniewska, et al. (2005) Structural basis for the regulation of insulin-like growth factors by IGF binding proteins. Structure (Camb) 103 155.
16. L Gauguin, B Klaproth, W Sajid, et al. (2008) Structural basis for the lower affinity of the insulin-like growth factors for the insulin receptor. J Biol Chem 283 2604.
17. M Kaleko, WJ Rutter and D Miller (1990) Overexpression of the human insulin-like growth factor-I receptor promotes ligand dependent neoplastic transformation. Mol Cell Biol 10 464.
18. H Werner and CT Roberts Jr (2003) The IGFI receptor gene: a molecular target for disrupted transcription factors. Genes Chrom Can 36 113.
19. J Du, XP Meng and P Delafontaine (1996) Transcriptional regulation of the insulin-like growth factor-I receptor gene: Evidence for protein kinase C dependent and independent pathways. Endocrinology 138 1378.
20. AM Abbott, R Bueno, MT Pedrin, et al. (1992) Insulin-like growth factor-I receptor gene structure. J Biol Chem 267 10759.
21. D LeRoith, H Werner, D Beitner-Johnson, et al. (1995) Molecular and cellular aspects of the insulin-like growth factor-I receptor. Endocrine Rev 16 143.
22. M Lou, TP Garrett, NM McKern, et al. (2006) The first three domains of the insulin receptor differ structurally from the insulin-like growth factor 1 receptor in the regions governing ligand specificity. Proc Natl Acad Sci U S A 103 12429.
23. M Keyhanfar, GW Booker, J Whittaker, et al. (2007) Precise mapping of an IGF-I binding site on the IGF-1R. Biochem J 401 269.
24. MC Lawrence, NM McKern and CW Ward (2007) Insulin receptor structure and its implications for the IGF-1 receptor. Curr Opin Struct Biol 17 699.
25. J Whittaker, AV Groth, DC Mynarcik, et al. (2001) Alanine scanning mutagenesis of a type I insulin-like growth factor receptor ligand binding site. J Biol Chem 276 43980.
26. J Wu, W Li, BP Craddock, et al. (2008) Small-molecule inhibition and activation-loop trans-phosphorylation of the IGF1 receptor. EMBO J 27 1985.
27. A Pautsch, A Zoephel, H Ahorn, et al. (2001) Crystal structure of bisphosphorylated IGF-1 receptor kinase: insight into domain movements upon kinase activation. Structure 9 955.
28. H Yamasaki, D Pager, S Gebremedhin, et al. (1992) Human insulin-like growth factor-I receptor 950 tyrosine is required for somatotroph growth factor signal transduction. J Biol Chem 267 20953.
29. MA Soos, CE Field and K Siddle (1993) Purified hybrid insulin/insulin-like growth factor-I receptors bind insulin-like growth factor-I but not insulin with high affinity. Biochem J 290 419.
30. G Pandini, F Frasca, R Mineo, et al. (2002) Insulin/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved. J Biol Chem 277 39684.
31. R Rotem-Yehudar, E Galperin and M Horowitz (2001) Association of insulin-like growth factor 1 receptor with EHD1 and SNAP29. J Biol Chem 276 33054.
32. R Navab, E Chevet, F Authier, et al. (2001) Inhibition of endosomal insulin-like growth factor-I processing by cysteine proteinase inhibitors blocks receptor-mediated functions. J Biol Chem 276 13644.
33. EA Bohula, AJ Salibury, M Sohail, et al. (2003) The efficacy of small interfering RNAs targeted to the type 1 insulin-like growth factor receptor (IGF1R) is influenced by secondary structure in the IGF1R transcript. J Biol Chem 278 15991.
34. S Li, M Resnicoff and R Boneya (1996) Effect of mutations at serines 1280–1281 on the mitogenic and transforming activities of the IGF-I receptor. J Biol Chem 271 12254.
35. T DeAngelis, A Ferber and R Baserga (1995) The insulin-like growth factor I receptor is a requirement for the mitogenic and transforming activities of the platelet derived growth factor receptor. J Cell Physiol 164 214.
36. C Sell, R Rubini, R Rubin, et al. (1993) Simian virus 40 large tumor antigen is unable to transform mouse embryo fibroblasts lacking type I insulin like growth factor receptor. Proc Natl Acad Sci U S A 90 11217.
37. JP Liu, J Baker, AS Perkins, et al. (1993) Mice carrying null mutations of the genes encoding insulin like growth factor I (IGF-I) and type 1 IGF receptor (IGF/r). Cell 75 73.
38. SR D'Mello, C Galli, T Ciott, et al. (1993) Induction of apoptosis in cerebellar granule neurons by low potassium: inhibition of death by insulin-like growth factor-I and cAMP. Proc Natl Acad Sci U S A 90 10989.
39. R Rubin and R Baserga (1995) Biology of disease: Insulin-like growth factor-I receptor: its role in cell proliferation, apoptosis, and tumorigenicity. Lab Invest 13 311.
40. TN Faria, VA Blakesley, H Kato, et al. (1994) Role of the carboxy-terminal domain of the insulin and insulin-like growth factor-I receptors in receptor function. J Biol Chem 269 13922.
41. XJ Sun, LM Wang, Y Zhang, et al. (1995) Role of IRS-2 in insulin and cytokine signaling. Nature 377 173.
42. G Pete, C. Fuller Cr, JM Oldham, et al. (1999) Postnatal growth responses to insulin-like growth factor I in insulin receptor substrate-1-deficient mice. Endocrinol 140 5478.
43. MJ Myers and MF White (1994) The IRS-1 signaling system. Trends in Biological Sciences 19 289.
44. MG Myers, XJ Sun, B Cheatham, et al. (1993) IRS-I is a common element in insulin and insulin-like growth factor I signalling to the phosphatidylinositol 5′-kinase. Endocrinology 132 1421.
45. DR Clemmons and LA Maile (2004) Interaction between insulin-like growth factor-I receptor and alphaVbeta3 integrin linked signaling pathways: cellular responses to change sin multiple signaling inputs. Mol Endocrinol 19 1.
46. PA Kiely, A Sant and R O'Connor (2002) RACK1 is an insulin-like growth factor 1 (IGF-1) receptor-interacting protein that can regulate IGF-I mediated Akt activation and protection from cell death. J Biol Chem 277 22581.
47. B Giovannone, E Lee, L Laviola, et al. (2003) Two novel proteins that are linked to insulin-like growth factor (IGF-I) receptors by the Grb10 adapter and modulate IGF-I signaling. J Biol Chem 278 31564.
48. S Dalle, W Ricketts, T Imamura, et al. (2001) Insulin and insulin-like growth factor I receptors utilize different G protein signaling components. J Biol Chem 276 15688.
49. MJ Myers and MF White (1996) Insulin signal transduction and the IRS proteins. Ann Rev Pharmacol 36 615.
50. MC Lauzier, EL Page, MD Michaud, et al. (2007) Differentiation regulation of hypoxia-inducible factor-1 through receptor tyrosine kinase transactivation in vascular smooth muscle cells. Endocrinol 148 4023-4031.
51. JL Holzman, L Liu, BJ Duke, et al. (2006) Transactivation of the IGF-1R aldosterone. Am J Physiol Renal Physiol 292 F1219.
52. RX Song, Z Zhang, Y Chen, et al. (2007) Estrogen signaling via a linear pathway involving insulin-like growth factor I receptor, matrix metalloproteinases, and epidermal growth factor receptor to activate mitogen-activated protein kinase in MCF-7 breast cancer cells. Endocrinol 148 4091.
53. M Verras and Z Sun (2005) 2005 Beta-Catenin is involved in insulin-like growth factor 1-mediated transactivation of the androgen receptor. Mol Endocrinol 19 391.
54. HM El-Shewy, FL Kelly, L Barki-Harrington, et al. (2004) Ectodomain shedding-dependent transactivation of epidermal growth factor receptors in response to insulin-like growth factor type 1. Mol Endocrinol 18 2727.
55. HD Venters, Q Tang, Q Liu, et al. (1999) A new mechanism of neurodegeneration: a proinflammatory cytokine inhibits receptor signaling by a survival peptide. Proc Natl Acad Sci U S A 96 9879.
56. J Brown, C Delaine, OJ Zaccheo, et al. (2008) Structure and functional analysis of the IGF-II/IGF2R interaction. EMBO J 27 265.
57. C Williams, D Rezgui, SN Prince, et al. (2007) Structural insights into the interaction of insulin-like growth factor 2 with IGF2R domain 11. Structure 15 1065.
58. MM Lau, CHE Stewart, Z Liu, et al. (1994) Loss of imprinted IGF-II cation independent mannose 6 phosphate receptor results in fetal overgrowth and perinatal lethality. Gene Dev 8 2953.
59. T McKinnon, C Chakraborty, L Gleeson, et al. (2001) Stimulation of human extravillous trophoblast migration by IGF-II is mediated by IGF type 2 receptor involving inhibitory G protein(s) and phosphorylation. J Clin Endocrinol Metab 86 3665.
60. JI Jones and DR Clemmons (1995) Insulin like growth factor and their binding proteins: biologic actions. Endocrine Rev 16 3.
61. MM Rechler (1993) Insulin like growth factor binding proteins. Vitamins and Hormones 47 1.
62. Y Imai, A Moralez, C Andag, et al. (2000) Substitutions for hydrophobic amino acids in the N-terminal domains of IGFBP-3 and -5 markedly reduce IGF-I binding and alter their biologic actions. J Biol Chem 275 18188.
63. LA Bach, SJ Headley and RS Norton (2005) IGF-binding proteins-the pieces are falling into place. Trends Endocrinol Metab 16 228.
64. Z Kuang, S Yao, KA McNeil, et al. (2007) Cooperativity of the N- and C-terminal domains of insulin-like growth factor (IGF) binding protein 2 in IGF binding. Biochem 46 13720.
65. JL Jones, A Gockerman, WH Busby Jr, et al. (1993) Insulin-like growth factor binding protein 1 stimulates cell migration and binds to the α5β1 integrin by means of its Arg-Gly-Asp sequence. Proc Natl Acad Sci U S A 90 10553.
66. BA Booth, M Boes, BL Dake, et al. (1996) Structure function relationships in the heparin binding C-terminal region of insulin-like growth factor binding protein-3. Growth Regul 6 206.
67. SK Durham, MR Keifer, BL Riggs, et al. (1994) Regulation of insulin like growth factor binding protein-4 by a specific insulin like growth factor binding protein-4 protease in normal human osteoblast like cells. Implications on human cell physiology. J Bone Mineral Res 9 111.
68. PL James, SB Jones, WH Busby, et al. (1993) IGF binding protein-5 is expressed in myoblast differentiation and is highly conserved. J Biol Chem 268 22305.
69. DR Clemmons (1997) Insulin-like growth factor binding proteins and their role in controlling IGF actions. Cytokine Growth Factor Rev 8 45.
70. JL Martin, KE Willetts and RC Baxter (1990) Purification and properties of a novel insulin-like growth factor-II binding protein from transformed human fibroblasts. J Biol Chem 265 4124.
71. G Aimaretti, M Boschetti, G Corneli, et al. (2008) Normal age-dependent values of serum insulin growth factor-1: results from a healthy Italian population. J Endocrinol Invest 31 455.
72. Y Hong, NL Pedesen, K Brismar, et al. (1996) Quantitative genetic analyses of insulin like growth factor I (IGF-I), IGF binding protein-1 and insulin levels in middle-aged and elderly twins. J Clin Endocrinol Metab 81 1791.
73. N Vaessen, P Heutink, JA Janssen, et al. (2001) A polymorphism in the gene for IGF-I: functional properties and risk for type 2 diabetes and myocardial infarction. Diabetes 50 637.
74. A Juul and NE Skakkebaek (1997) Prediction of the outcome of growth hormone provocative testing in short children by measurement of serum levels of insulin-like growth factor I and insulin-like growth factor binding protein 3. J Pediatr 130 197-204.
75. MB Ranke, R Schweizer, MW Elmlinger, et al. (2000) Significance of basal IGF-I, IGFBP-3 and IGFBP-2 measurements in the diagnostics of short stature in children. Horm Res 54 60.
76. A Juul, P Dalgaard, WF Blum, et al. (1995) Serum levels of insulin-like growth factor (IGF) binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation. J Clin Endocrinol Metab 80 2534.
77. H Mitchell, MT Dattani, V Naduri, et al. (1999) Failure of IGF-I and IGFBP-3 to diagnose growth hormone insufficiency. Arch Dis Child 80 443.
78. AA Jorge, SC Souza, IJ Arnhold, et al. (2002) Poor reproducibility of IGF-I and IGF binding protein-3 generation test in children with short stature and normal coding region of the GH receptor gene. J Clin Endocrinol Metab 87 469.
79. JO Jorgensen, TK Hansen, FL Conceicaso, et al. (2001) Short-term tools to measure responsiveness to growth hormone replacement. Horm Res 55(suppl 2), 40.
80. DR Clemmons, LE Underwood and EC Ridgeway (1979) Evaluation of acromegaly by radioimmunoassay of somatomedin-C. N Engl J Med 301 1138.
81. S Melmed (1990) Acromegaly. N Engl J Med 322 966.
82. B Stoffel-Wagner, W Springer, F Bidlingmaier, et al. (1997) A comparison of different methods for diagnosing acromegaly. Clin Endocrinol 46 531.
83. DR Clemmons (2006) Clinical utility of measurements of insulin-like growth factor 1. Nat Clin Pract Endocrinol Metab 2 436.
84. M Noel, D Chevenne and D Porquet (2001) Utility of insulin-like growth factor-I and its binding protein assays. Curr Opin Clin Nutr Metab Care 4 399.
85. JP Thissen, LE Underwood and JM Ketelslegers (1999) Regulation of insulin-like growth factor-I in starvation and injury. Nutr Rev 57 167.
86. B Tonshoff, D Kiepe and S Ciarmatori (2005) Growth hormone/insulin-like growth factor system in children with chronic renal failure. Pediatr Nephrol 20 279.
87. EF De Palo, M Bassanello, F Lancerin, et al. (2001) GH/IGF system, cirrhosis and liver transplantation. Clin Chim Acta 310 31.
88. A Bereket, CH Lang, SL Blethen, et al. (1995) Effect of insulin on the insulin-like growth factor system in children with new onset insulin dependent diabetes. J Clin Endocrinol Metab 80 1312.
89. LA Morrow, MB O'Brien, DE Moller, et al. (1994) Recombinant human insulin-like growth factor-I therapy improves glycemic control and insulin action in the type A syndrome of severe insulin resistance. J Clin Endocrinol Metab 79 205.
90. RC Baxter and JL Martin (1986) Radioimmunoassay of growth hormone dependent insulin-like growth factor binding protein in human plasma. J Clin Invest 78 1504.
91. WF Blum, K Albertsson-Wikland, S Rosberg, et al. (1993) Serum levels of insulin-like growth factor I (IGF-I) and IGF binding protein 3 reflect spontaneous growth hormone secretion. J Clin Endocrinol Metab 76 1610.
92. SR Leogney, RC Baxter, T Carrerato, et al. (1992) Structure and functional expression of acid-labile subunit of the insulin-like growth factor binding protein complex. Mol Endocrinol 6 870.
93. S Grinspoon, DR Clemmons, B Swearingen, et al. (1995) Serum insulin-like growth factor-binding protein-3 levels in the diagnosis of acromegaly. J Clin Endocrinol Metab 80 927.
94. T Laursen, A Flyvbjerg, JO Jorgensen, et al. (2000) Stimulation of the 150-kilodalton insulin-like growth factor binding protein-3 ternary complex by continuous and pulsatile patterns of growth hormone (GH) administration in GH-deficient patients. J Clin Endocrinol Metab 85 4310.
95. J Pfeilschifter, C Scheidt-Nave, G Leidig-Bruckner, et al. (1996) Relationship between circulating insulin-like growth factor components and sex hormones in a population based sample of 50- to 80-year-old men and women. J Clin Endocrinol Metab 81 2534.
96. JP Miell, AM Taylor, M Zini, et al. (1993) Effects of hypothyroidism and hyperthyroidism on insulin-like growth factors (IGFs) and growth hormone- and IGF binding proteins. J Clin Endocrinol Metab 76 950.
97. SR Kupfer, LE Underwood, RC Baxter, et al. (1993) Enhancement of the anabolic effects of growth hormone and insulin like growth factor-I by the use of both agents simultaneously. J Clin Invest 91 391.
98. LA Maile and JM Holly (1999) Insulin-like growth factor binding protein (IGFBP) proteolysis: occurrence, identification, role and regulation. Growth Horm IGF Res 9 85-95.
99. H Olausson, M Lof, K Brismar, et al. (2008) Longitudinal study of the maternal insulin-like growth factor system before, during and after pregnancy in relation to fetal and infant weight. Horm Res 69 99.
100. DR Clemmons, M Sleevi and WH Busby Jr (2005) Recombinant, nonglycosylated human insulin-like growth factor-binding protein-3 (IGFBP-3) is degraded preferentially after administration to type II diabetics, resulting in increased endogenous glycosylated IGFBP-3. J Clin Endocrinol Metab 90 6561.
101. WF Blum and BH Brier (1994) Radioimmunoassays for IGFs and IGFBPs. Growth Regulation 4 11.
102. GT Ooi, CC Orlowski, AL Brown, et al. (1990) Different tissue distribution and hormonal regulation of messenger RNAs encoding rat insulin-like growth factor binding proteins-1 and 2. Mol Endocrinol 4 321.
103. WH Daughaday, B Trivedi and RC Baxter (1993) Serum “big” insulin-like growth factor-II from patients with tumor hypoglycemia lacks normal E-domain O-linked glycosylation, a possible determinant of normal propeptide processing. Proc Natl Acad Sci U S A 90 5283.
104. A Bereket, CH Lang and TA Wilson (1999) Alterations in the growth hormone-insulin-like growth factor axis in insulin dependent diabetes mellitus. Horm Metab Res 31 172-181.
105. WJ Smith, LE Underwood and DR Clemmons (1995) Effects of Caloric or Protein Restriction on Insulin-Like Growth Factor-I (IGF-I) and IGF-Binding Proteins in Children and Adults. J Clin Endocrinol Metab 80 443.
106. DS Straus and CD Takemoto (1990) Effect of dietary protein deprivation insulin-like growth factor IGF-I and II, IGF binding protein-2 and serum albumin gene expression in the rat. Endocrinology 127 1849.
107. GT Ooi, LY Tseng, MQ Tran, et al. (1992) Insulin rapidly decreases insulin-like growth factor-binding protein-1 gene transcription in streptozotocin-diabetic rats. Mol Endocrinol 6 2219.
108. WH Busby, DK Snyder and DR Clemmons (1988) Radioimmunoassay of a 26,000 dalton plasma insulin like growth factor binding protein: control by nutritional variables. J Clin Endocrinol Metab 67 1225.
109. L Gan, H Pan and TG Unterman (2005) Insulin response sequence-dependent and independent mechanisms mediate effects of insulin on glucocorticoid-stimulated insulin-like growth factor binding protein-1 promoter activity. Endocrinol 146 4274.
110. RS Bar, M Boes, DR Clemmons, et al. (1990) Insulin differentially alters transcapillary movement of intravascular IGFBP-1, IGFBP-2 and endothelial cell IGF binding proteins in rat heart. Endocrinology 127 497.
111. M Westwood, JM Gibson, AC Williams, et al. (1995) Hormonal regulation of circulating insulin-like growth factor-binding protein-1 phosphorylation status. J Clin Endocrinol Metab 80 3520.
112. MS Lewitt, GS Denyer, GJ Cooney, et al. (1991) Insulin-like growth factor binding protein-1 modulates blood glucose levels. Endocrinol 129 2254.
113. SC Davies, JAH Wass, RJM Ross, et al. (1991) Induction of a specific protease for insulin-like growth factor binding protein-3 in the circulation during severe illness. J Endocrinol 130 469.
114. SH Scharla, DD Strong, C Rosen, et al. (1993) 1,25-Dihydroxyvitamin D3 increases secretion of insulin-like growth factor binding protein-4 (IGFBP-4) by human osteoblast-like cells in vitro and elevates IGFBP-4 serum levels in vivo. J Clin Endocrinol Metab 77 1190-1197.
115. C Ehrnborg, C Ohisson, S Mohan, et al. (2007) Increased serum concentration of IGFBP-4 and IGFBP-5 in healthy adults during one month's treatment with supraphysiological doses of growth hormone. Growth Horm IGF Res 17 234.
116. RP Rooman, LO De Beeck, M Martin, et al. (2002) IGF-I, IGF-II, free IGF-I and IGF-binding proteins-2 to -6 during high dose estrogen treatment in constitutionally tall girls. Eur J Endocrinol 146 823.
117. RC Baxter (2001) Changes in the IGF-IGFBP axis in critical illness. Best Pract Res Clin Endocrinol Metab 15 421.
118. M Houang, S Cabrol, L Perin, et al. (2000) Insulin-like growth factor-I (IGF-I), insulin-like growth factor binding proteins (IGFBP) and insulin-like growth factor type I receptor in children with various status of chronic renal failure. Growth Horm IGF Res 10 332.
119. VKM Han, AJ D'Ercole and PK Lund (1987) Cellular location of somatomedin (insulin-like growth factor) messenger RNA in the human fetus. Science 236 193.
120. CT Roberts, SR Lasky, WL Lowe, et al. (1987) Molecular coding of rat insulin-like growth factor-I complementary DNA: Differential messenger RNA processing of regulation by growth hormone in extrahepatic tissue. Mol Endocrinol 1 243.
121. J Isgaard, A Nilsson, A Vikma, et al. (1988) Growth hormone regulates the level of IGF-I mRNA in rat growth plate. Endocrinology 122 1515.
122. E Grundberg, H Brandstrom, KC Lam, et al. (2008) Systemic assessment of the human osteoblast transcriptome in resting and induced primary cells. Physiol Genomics 33 301-311.
123. DM Silver, H Fudo, D Halperin, et al. (1993) Differential expression of insulin like growth factor I (IGF-I) and IGF-II messenger ribonucleic acid in growing rat bone. Endocrinology 132 1158.
124. TL McCarthy, C Ji, M Centrella, et al. (2000) Links among growth factors. Hormones and nuclear factors with essential roles in bone formation. Crit Rev Oral Biol Med 11 409.
125. C Mendez-Davila, C Garcia-Moreno, C Trubi, et al. (2004) Effects of 17beta-estradiol, tamoxifen and raloxifene on the protein and mRNA expression of interleukin-6, transforming growth factor-beta1 and insulin-like growth factor-1 in primary human osteoblast cultures. J Endocrinol Invest 27 904.
126. CJ Rosen (2003) The cellular and clinical parameters of anabolic therapy for osteoporosis. Crit Rev Eukaryot Gene Expr 13 25.
127. B Sivan, P Lilos and Z Laron (2003) Effects of insulin-like growth factor-I deficiency and replacement therapy on the hematopoietic system in patients with Laron syndrome (primary growth hormone insensitivity). J Pediatr Endocrinol Metab 16 509.
128. T. Davidson Tr, CS Chamberlain, TS Bridges, et al. (2002) Effect of follicle size on in-vitro production of steroids and insulin-like growth factor (IGF-I), IGF-II, and the IGF binding proteins by equine ovarian granulosa cells. Biol Reprod 66 1640.
129. P Moyano and P Rotwein (2004) Mini-review: estrogen action in the uterus and insulin-like growth factor-I. Growth Horm IGF Res 14 431.
130. AJ D'Ercole and P Ye (July 31, 2008) Expanding the mind: IGF-I and brain development. Endocrinol epub
131. GP Cardona-Gomez, P Mendez, LL DonCarlos, et al. (2002) Interactions of estrogen and insulin-like growth factor-I in the brain: molecular mechanisms and functional implications. J Steroid Biochem Mol Biol 83 211.
132. ML Adamo and RP Farrar (2006) Resistance training, and IGF involvement in the maintenance of muscle mass during the aging process. Ageing Res Rev 5 310.
133. D Edwall, M Schalling, E Jennische, et al. (1989) Induction of insulin-like growth factor I messenger ribonucleic acid during regeneration of rat skeletal muscle. Endocrinol 124 820.
134. AC Paul and N Rosenthal (2002) Different modes of hypertrophy in skeletal muscle fibers. J Cell Biol 156 751.
135. JR McMullen and S Izumo (2006) Role of the insulin-like growth factor I (IGFI)/phosphoinositide-3-kinase (PI3K) pathway mediating physiological cardiac hypertrophy. Novartis Found Symp 274 90.
136. SA Cooper, A Whaley-Connell, J Habibi, et al. (2007) Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance. Am J Physiol Heart Circ Physiol 293 2009.
137. B Cercek, MC Fishbein, JS Forrester, et al. (1990) Induction of insulin-like growth factor I messenger RNA in rat aorta after balloon denudation. Circ Res 66 1755.
138. S Eleswarapu, Z Gu and H Jiang (2008) Growth hormone regulation of insulin-like growth factor-I gene expression may be mediated by multiple distal signal transducer and activator of transcription 5 binding sites. Endocrinol 249 2230.
139. WL Lowe, M Adamo, H Werner, et al. (1989) Regulation by fasting of insulin-like growth factor I and its receptor: Effects on gene expression and binding. J Clin Invest 84 619.
140. ST Butler, AL Marr, S. Pelton Sh, et al. (2003) Insulin restores GH responsiveness during lactation-induced negative energy balance in dairy cattle: effects on expression of IGF-I and GH receptor. J Endocrinol 176 205.
141. P Rotwein, KM Pollack, M Watson, et al. (1987) Insulin-like growth factor gene expression during rat embryonic development. Endocrinology 121 2141.
142. R Hirschberg (1993) The physiology and pathophysiology of IGF-I in the kidney. Adv Exp Med Biol 343 345.
143. A Flyvbjerg, WF Bennett, R Rasch, et al. (1999) Compensatory renal growth in uninephrectomized adult mice is growth hormone dependent. Kidney Int 56 2048.
144. J Dupont, A Pierre, P Froment, et al. (2003) The insulin-like growth factor axis in cell cycle progression. Horm Metab Res 35 740.
145. S Travali, K Reiss, A Ferber, et al. (1991) Constitutively expressed c-myb abrogates the requirement for insulin-like growth factor-I in 3T3 fibroblasts. Mol Cell Biol 11 731.
146. D Coppola, A Ferber, A Miura, et al. (1994) A functional insulin-like growth factor I receptor is required for the mitogenic and transforming activities of the epidermal growth factor receptor. Mol Cell Biol 14 4588.
147. Z Pietrzkowski, R Lammers, G Carpenter, et al. (1992) Constitutive expression of insulin-like growth factor-I and insulin-like growth factor-I receptor abrogates all requirements for exogenous growth factors. Cell Growth and Differentiation 3 199.
148. WL Lowe (1991) Biologic actions of the insulin-like growth factors. D LeRoith,(Ed.) Insulin-like Growth Factors: Molecular and Cellular Aspects Boca Raton: CRC Press 49.
149. O Nilsson, R Marino, F De Luca, et al. (2005) Endocrine regulation of the growth plate. Horm Res 64 157.
150. RF Loeser and G Shanker (2000) Autocrine stimulation by insulin-like growth factor 1 and insulin like growth factor 2 mediates chondrocyte survival in vitro. Arthritis Rheum 43 1552.
151. H Madry, D Zurakowski and SB Trippel (2001) Overexpression of human insulin-like growth factor-I promotes new tissue formation in an ex vivo model of articular chrondrocyte transplantation. Gene Ther 8 1443.
152. S Yakar and C Rosen (1998) From mouse to man: redefining the role of insulin-like growth factor-I in the acquisition of bone mass. Pro Soc Expo Biol Med 228 245.
153. M Zhang, S Xuan, ML Bouxsein, et al. (2002) Osteoblast-specific knockout of the insulin-like growth factor (IGF) receptor gene reveals an essential role of IGF signaling in bone matrix mineralization. J Biol Chem 277 44005.
154. G Zhao, MC Monier-Faugere, MC Langub, et al. (2000) Targeted overexpression of insulin-like growth factor I in osteoblasts of transgenic mice: increased trabecular bone volume without increased osteoblast proliferation. Endocrinol 141 2674.
155. Y Wang, S Nishida, BM Boudignon, et al. (2007) IGF-I receptor is required for the anabolic actions of parathyroid hormone on bone. J Bone Miner Res 22 1329.
156. K Sjogren, M Sheng, S Moverare, et al. (2002) Effects of liver-derived insulin-like growth factor I on bone metabolism in mice. J Bone Miner Res 17 1977.
157. T Takahashi, K Ishida, K Itoh, et al. (2003) IGF-I gene transfer by electroporation promotes regeneration in a muscle injury model. Gene Ther 10 612.
158. J Banu, L Wang and DN Kalu (2003) Effects of increased muscle mass on bone in male mice overexpressing IGF-I in skeletal muscles. Calcif Tissue Int 73 196.
159. S Welsh, D Plank, S Witt, et al. (2002) Cardiac-specific IGF-1 expression attenuates dilated cardiomyopathy in tropomodulin-overexpressing transgenic mice. Circ Res 90 641.
160. B Zhu, G Zhao, DP Witte, et al. (2001) Targeted overexpression of IGF-I in smooth muscle cells of transgenic mice enhances neointimal formation through increased proliferation and cell migration after intraarterial injury. Endocrinol 142 3598.
161. Y Cao, AJ Gunn, L Bennet, et al. (2003) Insulin-like growth factor (IGF)-1 suppresses oligodendrocyte caspase-3 activation and increases glial proliferation after ischemia in near-term fetal sheep. J Cereb Blood Flow Metab 23 739.
162. K Homma, Y Koriyama, K Mawatari, et al. (2007) Early down-regulation of IGF-I decides the fate of rat retinal ganglion cells after optic nerve injury. Neurochem Int 50 741.
163. C Vicario-Abejon, MJ Yusta-Boyo, C Fernandez-Moreno, et al. (2003) Locally born olfactory bulb stem cells proliferate in response to insulin-related factors and require endogenous insulin-like growth factor-I for differentiation into neurons and glia. J Neurosci 23 895.
164. P Ye, YZ Xing, ZH Dai, et al. (1996) In vivo actions of insulin-like growth factor-I (IGF-I) on cerebellum development in transgenic mice: Evidence that IGF-I increases proliferation of granule cell progenitors. Dev Brain Res 95 44.
165. JM Bateman and H McNeill (2006) Insulin/IGF signaling in neurogenesis. Cell Mol Life Sci 63 1701.
166. K Muta and B Krontes (1993) Apoptosis of human erythroid colony forming cells is decreased by stem cell factor and insulin-like growth factor-I as well as erythropoietin. J Cell Physiol 156 264.
167. G Rodriguez-Tarduchy, MKL Collins, I Garcia, et al. (1992) Insulin-like growth factor I inhibits apoptosis in IL-3 dependent hematopoietic cells. J Immunol 149 535.
168. JR Florini, DZ Ewton and SL Root (1991) IGF-I stimulates terminal myogenic differentiation by induction of myogenin gene expression. Mol Endocrinol 5 718.
169. S Palmer, G Myerson, E Lindgren, et al. (1991) Insulin-like growth factor-I shifts from promoting cell division to potentiating maturation during normal differentiation. Proc Natl Acad Sci USA 88 9994.
170. F Khamsi, S Roberge, Y Yavas, et al. (2001) Recent discoveries in physiology of insulin-like growth factor-1 and its interaction with gonadotropins in folliculogenesis. Endocrine 16 151-165.
171. S Mesiano and RB Jaffe (1997) Role of growth factors in the developmental regulation of the human fetal adrenal cortex. Steroids 62 62.
172. H Yamasaki, D Prager, S Gebremedhin, et al. (1991) Insulin-like growth factor-I (IGF-I) attenuation of growth hormone is enhanced by overexpression of pituitary IGF-I receptors. Mol Endocrinol 5 890.
173. C Duan, S Hawes, T Prevette, et al. (1996) Insulin like growth factor-I (IGF-I) stimulates IGF binding protein-5 synthesis through transcriptional activation of the gene in aortic smooth muscle cells. J Biol Chem 271 4280.
174. EE Spangenburg, DK Bowles and FW Booth (2003) IGF-I induced transcriptional activity of the skeletal {alpha} action gene is regulated by signaling mechanisms linked to voltage-gated calcium channels during myoblast differentiation. Endocrinol 145 2054.
175. J Dupont, AM Fernandez, CA Glackin, et al. (2001) Insulin-like growth factor 1 (IGF-1) induced twist expression is involved in the anti-apoptotic effects of the IGF-I receptor. J Biol Chem 276 26699.
176. C Mulligan, J Rochford, G Denyer, et al. (2002) Microarray analysis of insulin and insulin-like growth factor-1 (IGF-1) receptor signaling reveals the selective up-regulation of the mitogen heparin-binding EGF-like growth factor by IGF-1. J Biol Chem 277 42480.
177. M Grohmann, E Foulstone, G Welsh, et al. (2005) Isolation and validation of human prepubertal skeletal muscle cells: maturation and metabolic effects of IGF-I, IGFBP-3 and TNFalpha. J Physiol 568 229.
178. B Zheng and DR Clemmons (1998) Blocking ligand occupancy of the αVβ3 integrin inhibits IGF-I signaling in vascular smooth muscle cells. Proc Natl Acad Sci U S A 95 11217.
179. AA Samani, S Yakar, D LeRoith, et al. (2007) The role of the IGF system in cancer growth and metastasis: overview and recent insights. Endocr Rev 28 20.
180. S Yakar, D LeRoith and P Brodt (2005) The role of the growth hormone/insulin-like growth factor axis in tumor growth and progression: lessons from animal models. Cytokine and Growth Fact Rev 16 407.
181. RA Sayer, JM Lancaster, J Pittman, et al. (2005) High insulin-like growth factor-2 (IGF-2) gene expression is an independent predictor of poor survival for patients with advanced stage serous epithelial ovarian cancer. Gynecol Oncol 96 355.
182. M Haruta, Y Arai, W Sugawara, et al. (2008) Duplication of paternal IGF2 or loss of maternal IGF2 imprinting occurs in half of Wilms tumors with various structural WT1 abnormalities. Genes Chrom Can 47 712.
183. RC Baxter and WH Daughaday (1991) Impaired function of the ternary insulin like growth factor binding complex in patients with hypoglycemia due to non-islet cell tumors. J Clin Endocrinol Metab 73 696.
184. D Sachdev, JS Hartell, AV Lee, et al. (2004) A dominant negative type I insulin-like growth factor receptor inhibits metastasis of human cancer cells. J Biol Chem 279 5017.
185. J DiGiovanni, K Kiguchi, A Frijhoff, et al. (2000) Deregulated expression of insulin-like growth factor 1 in prostate epithelium leads to neoplasia in transgenic mice. Proc Natl Acad Sci U S A 97 3455.
186. KD Wu, L Zhou, D Burtrum, et al. (2007) Antibody targeting of the insulin-like growth factor I receptor enhances the anti-tumor response of multiple myeloma to chemotherapy through inhibition of tumor proliferation and angiogenesis. Cancer Immunol Immunother 56 343.
187. JD Wu, et al. (2005) In-vivo effects of the human type I insulin-like growth factor receptor antibody A12 on androgen-dependent and androgen-independent human prostate tumors. Clin Cancer Res 11 3065.
188. S Miyamoto, et al. (2005) Blockade of paracrine supply of insulin-like growth factors using neutralizing antibodies suppresses the liver metastasis of human colorectal cancers. Clin Cancer Res 11 3494.
189. J Fowlkes, JJ Enghild, N Suzukik, et al. (1994) Matrix metalloproteases degrade insulin like growth factor binding protein-3 in dermal fibroblast cultures. J Biol Chem 269 25742.
190. JB Lawrence, C Oxvig, MT Overgaard, et al. (1999) The insulin-like growth factor (IGF-I)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A. Proc Natl Acad Sci USA 196 3149.
191. TC Nichols, WH Busby Jr, E Merricks, et al. (2007) Protease-resistant insulin-like growth factor (IGF) binding protein-4 inhibits IGF-I actions and neointimal expansion in a porcine model of neointimal hyperplasia. Endocrinol 148 5002.
192. SM Leal, Q Liu, GS Huang, et al. (1997) The type V transforming growth factor beta receptor is a putative insulin like growth factor binding protein 3 receptor. J Biol Chem 272 20572.
193. DR Clemmons (2001) Use of mutagenesis to probe IGF binding protein structure/function relationships. Endocr Rev 22 800.
194. MM Rechler and DR Clemmons (1998) Regulatory actions in insulin-like growth factor binding proteins. Trends Endocrinol Metab 9 176.
195. WW Burch, J Correa, JE Shaveley, et al. (1990) The 25 k Dalton insulin-like growth factor (IGF) binding protein inhibits both basal and IGF mediated growth in chick embryonic pelvic cartilage in vitro. J Clin Endocrinol Metab 70 173.
196. C Fottner, G Spottl and MM Weber (2007) The divergent effect of insulin-like growth factor binding protein (IGFBP)-1 on IGF induced steroidogenesis in bovine adrenocortical cells is not due to its phosphorylation status. Exp Clin Endocrinol Diabetes 115 232.
197. S Kajimura, K Aida and C Duan (2006) Understanding hypoxia-induced gene expression in early development: in vitro and in vivo analysis of hypoxia-inducible factor-1 regulated zebra fish insulin-like growth factor binding protein gene expression. Mol Cell Biol 26 1142.
198. A Marchand, C Tomkiewicz, L Magne, et al. (2006) Endoplasmic reticulum stress induction of insulin-like growth factor-binding protein-1 involves ATF4. J Biol Chem 281 19124.
199. E Wolf, H Lahm, M Wu, et al. (2000) Effects of IGFBP-2 overexpression in vitro and in vivo. Pediatr Nephrol 14 572.
200. RS Bar, BA Booth, M Bowes, et al. (1989) Insulin-like growth factor binding proteins from cultured endothelial cells: purification, characterization, and intrinsic biologic activities. Endocrinology 125 1910.
201. VC Russo, BS Schutt, E Andaloro, et al. (2005) Insulin-like growth factor binding protein-2 binding to extracellular matrix plays a critical role in neuroblastoma cell proliferation, migration and invasion. Endocrinol 146 4445.
202. D Kiepe, A Van der Pas, S Ciarmatori, et al. (2008) Defined carboxy-terminal fragments of insulin-like growth factor binding protein-2 exert similar mitogenic activity on cultures rat growth plate chondrocytes as IGF-I. Endocrinol 149 4901-4911.
203. H Wang, H Wang, W Shen, et al. (2003) Insulin-like growth factor binding protein 2 enhances glioblastoma invasion by activating invasion-enhancing genes. Cancer Res 63 4315.
204. CA Conover, EW Johnstone, RT Turner, et al. (2002) Subcutaneous administration of insulin-like growth factor (IGF)-II/IGF binding protein-2 complex stimulates bone formation and prevents loss of bone mineral density in a rat model of disuse osteoporosis. Growth Horm IGF Res 12 178.
205. CC Zhang, M Kaba, S Iizuka, et al. (2008) Angiopoietin-like 5 and IGFBP2 stimulate ex-vivo expansion of human cord blood hematopoietic stem cells as assayed by NOD/SCID transplantation. Blood 111 3415.
206. D Chesik, J De Keyser and N Wilczak (2007) Insulin-like growth factor binding protein-2 as a regulator of IGF actions in CNS: implications in multiple sclerosis. Cytokine & Growth Factor Reviews 18 267.
207. KS Strange, D Wilkinson and JT Emerman (2002) Mitogenic properties of insulin-like growth factors I and II, insulin-like growth factor binding protein-3 and epidermal growth factor on human breast carcinoma cells. Breast Cancer Res Treat 75 203.
208. JM Ricort and M Binoux (2002) Insulin-like growth factor binding protein-3 activates a phosphotyrosine phosphatase. Effects on the insulin-like growth factor signaling pathway. J Biol Chem 277 19448.
209. JL Martin and S Jambazov (2006) Insulin-like growth factor binding protein-3 in extracellular matrix stimulates adhesion of breast epithelial cells and activation of p44/42 mitogen-activated protein kinase. Endocrinol 147 4400.
210. H Huynh, XF Yang and M Pollak (1996) Estradiol and antiestrogens regulate a growth-inhibitory insulin-like growth factor binding protein 3 autocrine loop in human breast cancer cells. J Biol Chem 271 1016.
211. L O'Rear, L Longobardi, M Torello, et al. (2005) Signaling cross talk between IGF-binding protein-3 and transforming growth factor (beta) in mesenchymal chondroprogenitor cell growth. J Mol Endocrinol 34 723.
212. JV Silha, PC Sheppard, S Mishra, et al. (2006) Insulin-like growth factor (IGF) binding protein-3 attenuates prostate tumor growth by IGF-dependent and IGF-independent mechanisms. Endocrinol 147 2112.
213. B Liu, HY Lee and SA Weinzimer (2000) Direct functional interactions between insulin-like growth factor-binding protein-3 and retinoid X receptor- regulate transcriptional signaling and apoptosis. J Biol Chem 275 33607.
214. LJ Schedlich, TF Young, SM Fifth, et al. (1998) Insulin-like growth factor-binding protein (IGFBP)-3 and IGFBP-5 share a common nuclear transport pathway in T47D human breast carcinoma cells. J Biol Chem 273 18347.
215. M Takaoka, SH Kim, T Okawa, et al. (2007) IGFBP-3 regulated esophageal tumor growth through IGF-dependent and independent mechanisms. Cancer Biol Ther 6 534.
216. SS Chan, SM Twigg, SM Firth, et al. (2005) Insulin-like growth factor binding protein-3 leads to insulin resistance in adipocytes. J Clin Endocrinol Metab 90 6588.
217. S Mohan, CM Bautista, J Wergedal, et al. (1989) Isolation of inhibitory insulin-like growth factor (IGF) binding protein from bone cell conditioned medium: a potential local regulator of IGF action. Proc Natl Acad Sci U S A 86 8338.
218. CA Conover, SK Durham, J Zapf, et al. (1995) Cleavage analysis of insulin-like growth factor (IGF)-dependent IGF-binding protein-4 proteolysis and expression of protease-resistant IGF-binding protein-4 mutants. J Biol Chem 270 4395.
219. LJ Spicer (2003) Proteolytic degradation of insulin-like growth factor binding proteins by ovarian follicles. Biol Reprod 70 1223.
220. A Parker, C Rees, JB Clarke, et al. (1998) Binding of insulin-like growth factor binding protein-5 to smooth muscle cell extracellular matrix is a major determinant of the cellular response to IGF-I. Mol Biol Cell 9 2383.
221. N Miyakoshi, C Richman, Y Kasukawa, et al. (2001) Evidence that IGF-binding protein-5 functions as a growth factor. J Clin Invest 107 71.
222. JF Kuemmerle and H Zhou (2002) Insulin-like growth factor-binding protein-5 (IGFBP-5) stimulates growth and IGF-I secretion in human intestinal smooth muscle by Ras-dependent activation of p38 MAP kinase and Erk1/2 pathways. J Biol Chem 277 20563.
223. AJ Butt, KA Dickson, F McDougall, et al. (2003) Insulin-like growth factor-binding protein-5 inhibits the growth of human breast cancer cells in vitro and in vivo. J Biol Chem 278 29676.
224. E Marshman, KA Green, DJ Flint, et al. (2003) Insulin-like growth factor binding protein-5 and apoptosis in mammary epithelial cells. J Cell Sci 116 675.
225. AJ Butt, KA Dickson, S Jambazov, et al. (2005) Enhancement of tumor necrosis factor-alpha-induced growth inhibition by insulin-like growth factor-binding protein-5 (IGFBP-5), but not IGFBP-3 in human breast cancer cells. Endocrinol 146 3113.
226. A Mukherjee, EM Wilson and P Rotwein (2008) Insulin-like growth factor (IGF) binding protein-5 blocks skeletal muscle differentiation by inhibiting IGF actions. Mol Endocrinol 22 206.
227. LA Bach (2005) IGFBP-6 five years on; not so “forgotten”? Growth Horm IGF Res 15 185.
228. D Kiepe, T Ulinski, DR Powell, et al. (2002) Differential effects of insulin-like growth factor binding proteins 1, -2, -3 and -6 on cultured growth plate chondrocytes. Kidney Int 62 1591.
229. P Fu, JA Thomson and LA Bach (2007) Promotion of cancer cell migration: an insulin-like growth factor (IGF) independent action of IGF-binding protein-6. J Biol Chem 282 22298.
230. L Guo, YY Zhao, YY Zhao, et al. (2007) Toxic effects of ICDD on osteogenesis through altering IGFBP-6 gene expression in osteoblasts. Biol Pharm Bull 30 2018.
231. RG Douglas, PD Gluckman, B Ball, et al. (1991) The effects of infusion of insulin-like growth factor I (IGF-I), IGF-II and insulin on glucose and protein metabolism in fasted lambs. J Clin Invest 88 614.
232. D Chrysis, J Zhang and LE Underwood (2002) Divergent regulation of proteasomes by insulin-like growth factor I and growth hormone in skeletal muscle of rats made catabolic with dexamethasone. Growth Horm IGF Res 12 434.
233. CH Lang and RA Frost (2002) Role of growth hormone, insulin-like growth factor-I and insulin-like growth factor binding proteins in the catabolic response to injury and infection. Curr Opin Nutr Metab Care 5 271.
234. JP Thissen, LE Underwood, DM Maiter, et al. (1991) Failure of IGF-I infusion to promote growth in protein-restricted rats despite normalization of serum IGF-I concentrations. Endocrinology 128 885.
235. RJ Jacob, RS Sherwin, L Bowen, et al. (1991) Metabolic effects of IGF-I and insulin in spontaneously diabetic BB/w rats. Am J Physiol 260 E262.
236. GN Cox, MJ McDermott, E Merkel, et al. (1994) Recombinant human insulin-like growth factor binding protein-1 inhibits growth stimulated by IGF-I and growth hormone in hypophysectomized rats. Endocrinol 35 1913.
237. RD Galiano, L Zhao, DR Clemmons, et al. (1996) Interaction between the insulin-like growth factor family and the integrin receptor family in tissue repair processes. J Clin Invest 98 2462.
238. JI Leu, MA Crissey and R Taub (2003) Massive hepatic apoptosis associated with TGF-beta1 activation after Fas ligand treatment of IGF binding protein-1-deficient mice. J Clin Invest 111 129.
239. C Palermo, P Manduca, E Gazzerro, et al. (2004) Potentiating role of insulin-like growth factor binding protein (IGFBP)-2 on IGF-II-stimulated alkaline phosphatase activity in differentiating osteoblasts. Am J Physiol Endocrinol Metab 286 E648.
240. CM Bagi, R Brommage, SO Adams, et al. (1994) Benefit of systemically administered rh IGF-I and rh IGF-I/IGBP-3 on cancellous bone in oophorectomized rats. J Bone Mineral Res 9 1301.
241. HS Kim, O Ali, M Shim, et al. (2007) Insulin-like growth factor binding protein-3 induces insulin resistance in adipocytes in vitro and in rats in vivo. Pediatr Res 61 159.
242. W Chen, KV Salojin, QS Mi, et al. (2004) Insulin-like growth factor (IGF)-I/IGF-binding protein-3 complex: therapeutic efficacy and mechanism of protection against type 1 diabetes. Endocrinol 145 627.
243. G Zappala, C Elbi, J Edwards, et al. (2007) Induction of apoptosis in human prostate cancer cells by insulin-like growth factor binding protein-3 does not require binding to retinoid X receptor-alpha. Endocrinol 149 1802.
244. P Fang, V Hwa, BM Little, et al. (2007) IGFBP-3 sensitizes prostate cancer cells to interferon-gamma-induced apoptosis. Growth Horm IGF Res 18 38.
245. N Miyakoshi, X Qin, Y Kasukawa, et al. (2001) Systemic administration of insulin-like growth factor (IGF) binding protein-4 (IGFBP-4) increases bone formation parameters in mice by increasing IGF bioavailability via an IGFBP-4 protease-dependent mechanism. Endocrinol 142 2641.
246. DL Andress (2001) IGF-binding protein-5 stimulates osteoblast activity and bone accretion in ovariectomized mice. Am J Physiol Endocrinol Metab 281 283.
247. RR Behringer, TM Lewin, CJ Quaife, et al. (1990) Expression of insulin-like growth factor I stimulates normal somatic growth in growth hormone deficient transgenic mice. Endocrinology 127 1033.
248. D Chrysis, AS Calikoglu, P Ye, et al. (2001) Insulin-like growth factor-I overexpression attenuates cerebellar apoptosis by altering the expression of Bcl family proteins in a developmentally specific manner. J Neurosci 21 1481.
249. A Dai, Y Xing, CM Boney, et al. (1994) Human insulin-like growth factor binding protein-1 (hIGFBP-1) transgenic mice: characterization and insights into the regulation of IGFBP-1 expression. Endocrinology 135 1316.
250. K Rajkumar, D Barron, M Lewitt, et al. (1995) Growth retardation and hyperglycemia in insulin-like growth factor binding protein-1 transgenic mice. Endocrinology 136 4029.
251. CS Watson, P Bialek, M Anzo, et al. (2006) Elevated circulating insulin-like growth factor binding protein-1 is sufficient to cause fetal growth restriction. Endocrinol 147 1175.
252. N Ben Lagha, P Menuelle, P Seurin, et al. (2002) Bone formation in the context of growth retardation induced by hIGFBP-1 overexpression in transgenic mice. Connect Tissue Res 43 515.
253. F Eckstein, T Pavicic, S Nedbal, et al. (2003) Insulin-like growth factor binding protein-2 (IGFBP-2) overexpression negatively regulates bone size and mass, but not density, in the absence and presence of growth hormone/IGF-I excess in transgenic mice. Anat and Embryology 206 139.
254. VE DeMambro, DR Clemmons, LG Horton, et al. (2008) Gender-specific changes in bone turnover and skeletal architecture in IGFBP-2 null mice. Endocrinol 149 2051.
255. JV Silha, S Mishra, CJ Rosen, et al. (2003) Perturbations in bone formation and resorption in insulin-like growth factor binding protein-3 transgenic mice. J Bone Miner Res 18 1834.
256. JV Silha, Y Gui, S Mishra, et al. (2004) Overexpression of gly56/gly80/gly81-mutant insulin-like growth factor binding protein-3 in transgenic mice. Endocrinol 146 1523.
257. L Liao, X Chen, S Wang, et al. (2008) Steroid receptor coactivator 3 maintains circulating insulin-like growth factor I (IGF-I) by controlling IGF-binding protein 3 expression. Mol Cell Biol 28 2460.
258. Y Ning, AG Schuller, S Bradshaw, et al. (2006) Diminished growth and enhanced glucose metabolism in triple knockout mice containing mutations of insulin-like growth factor binding protein-3, -4, and -5. Mol Endocrinol 20 2173.
259. M Zhang, MC Faugere, H Malluche, et al. (2003) Paracrine overexpression of IGFBP-4 in osteoblasts of transgenic mice decreases bone turnover and causes global growth retardation. J Bone Miner Res 18 836.
260. Y Ning, AG Schuller, CA Conover, et al. (2008) Insulin-like growth factor (IGF) binding protein-4 is both a positive and negative regulator of IGF activity in vivo. Mol Endocrinol 22 1213.
261. D. Salih Da, G Tripathi, C Holding, et al. (2004) Insulin-like growth factor binding protein 5 (IGFBP-5) compromises survival, growth, muscle development, and fertility in mice. Proc Natl Acad Sci U S A 101 4314.
262. JV Silha, Y Gui, T Modric, et al. (2001) Overexpression of the acid-labile subunit of the IGF ternary complex in transgenic mice. Endocrinol 142 4305.
263. HM Domene, SV Bengolea, HG Jasper, et al. (2005) Acid-labile subunit deficiency: phenotypic similarities and differences between human and mouse. J Endocrinol Invest 28 43.
264. J Baker, JP Liu, EJ Robertson, et al. (1993) Role of insulin like growth factors in embryonic and postnatal growth. Cell 75 83.
265. M Holzenberger, P Leneuve, G Hamard, et al. (2000) A targeted partial invalidation of the insulin-like growth factor receptor gene in mice causes a postnatal growth deficit. Endocrinol 141 2557.
266. T Kondo, D Vicent, K Suzuma, et al. (2003) Knockout of insulin and IGF-I receptors on vascular endothelial cells protects against retinal neovascularization. J Clin Invest 111 1835.
267. RM DeChiara, A Efstratiadis and EJ Robertson (1990) A growth deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disruption. Nature 345 78.
268. K Sjogren, JL Liu, K Blad, et al. (1999) Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice. Proc Natl Acad Sci U S A 96 7088.
269. S Yakar, CJ Rosen, WG Beamer, et al. (2002) Circulating levels of IGF-I directly regulate bone growth and density. J Clin Invest 110 771.
270. I Ueki, GT Ooi, ML Tremblay, et al. (2000) Inactivation of the acid labile subunit gene in the mice results in mild retardation of postnatal growth despite profound disruptions in the circulating insulin-like growth factor system. Proc Natl Acad Sci U S A 97 6868.
271. Y Wu, H Sun, S Yakar, et al. (2009, Epub ahead of print) Elevated levels of IGF-1 in serum rescue the severe growth retardation of IGF-1 null mice. Endocrinology
272. H-P Guler, J Zapf and ER Froesch (1987) Short-term metabolic effects of recombinant human insulin-like growth factor-I in healthy adults. N Engl J Med 317 137.
273. D Kerr, V Tamborlane, F Rife, et al. (1993) Effect of insulin-like growth factor-I on the responses to and recognition of hypoglycemia in humans. A comparison with insulin. J Clin Invest 91 141.
274. DR Clemmons, A Smith-Banks, AC Celniker, et al. (1992) Reversal of diet-induced catabolism by infusion of recombinant insulin-like growth factor-I (IGF-I) in humans. J Clin Endocrinol Metab 75 234.
275. DN Herndon, PI Ramzy, MA DebRoy, et al. (1999) Muscle protein catabolism after severe burn: effects of IGF-1/IGFBP-3 treatment. Ann Surg 229 713.
276. MG Jeschke, U Bolder, DH Chung, et al. (2007) Gut mucosal homeostasis and cellular mediators after severe thermal trauma and the effect of insulin-like growth factor-1 in combination with insulin-like growth factor binding protein-3. Endocrinol 148 354.
277. S Boonen, C Rosen, R Bouillon, et al. (2002) Musculoskeletal effects of the recombinant human IGF-I/IGF binding protein-3 complex in osteoporotic patients with proximal femoral fracture: a double-blind, placebo-controlled pilot study. J Clin Endocrinol Metab 87 1593.
278. R Deicher and WH Horl (2005) Hormonal adjuvants for the treatment of renal anaemia. Eur J Clin Invest 35(suppl 3), 75.
279. N Mauras, PM Martha Jr, V Quarmby, et al. (1997) rhIGF-I administration in humans: metabolic effects of bolus vs continuous subcutaneous delivery. Am J Physiol 272 E628.
280. N Mauras and MW Haymond (2005) Are the metabolic effects of GH and IGF-I separable? Growth Horm IGF Res 15 19.
281. N Mauras and B Beaufree (1995) Recombinant human insulin like growth factor I enhances whole-body protein anabolism and significantly diminishes the protein catabolic effects of prednisone in humans without a diabetogenic effect. J Clin Endocrinol Metab 80 869.
282. PR Ebling, JD Jones, WM O'Fallon, et al. (1993) Short term effects of recombinant human insulin like growth factor I on bone turnover in normal women. J Clin Endocrinol Metab 77 1384.
283. S Grinspoon, HBA Baum, K Lee, et al. (1996) Effects of short term rhIGF-I on bone turnover in osteopenic women with anorexia nervosa. J Clin Endocrinol Metab 81 3364.
284. AG Johansson, E Lindh, WF Blum, et al. (1996) Effects of growth hormone and insulin-like growth factor-I in men with osteoporosis. J Clin Endocrinol Metab 81 44.
285. T Biandi, Y Glatz, R Bouillon, et al. (1998) Effects of short term insulin-like growth factor-I (IGF-I) or growth hormone treatment on bone metabolism and on production of 1,25 dihydroxycholecalciferol in GH deficient adults. J Clin Endocrinol Metab 83 81.
286. JM Liu, HY Zhao, G Ning, et al. (2008) IGF-1 as an early marker for low bone mass or osteoporosis in premenopausal and postmenopausal women. J Bone Miner Metab 26 159.
287. M Haluzik, S Yakar, O Gavrilova, et al. (2003) Insulin resistance in the liver-specific IGF-1 gene-deleted mouse is abrogated by deletion of the acid-labile subunit of the IGF-binding protein-3 complex: relative roles of growth hormone and IGF-1 in insulin resistance. Diabetes 52 2483.
288. VA Ezzat, ER Duncan, SB Wheatcroft, et al. (2008) The role of IGF-I and its binding proteins in the development of type 2 diabetes and cardiovascular disease. Diabetes Obesity and Metab 10 198.
289. T Pratipanawatr, W Pratipanawatr, C Rosen, et al. (2002) Effect of IGF-I on FFA and glucose metabolism in control and type 2 diabetic subjects. Am J Physiol Endocrinol Metab 282 E1360.
290. HL Simpson, NC Jackson, F Shojaee-Moradie, et al. (2004) Insulin-like growth factor I has a direct effect on glucose and protein metabolism, but not effect on lipid metabolism in type 1 diabetes. J Clin Endocrinol Metab 89 425.
291. H Kuzuya, N Matsuura, M Sakamoto, et al. (1993) Trial of insulin-like growth factor-I therapy for patients with extreme insulin resistance syndromes. Diabetes 42 696.
292. TD Cheetham, J Jones, AM Taylor, et al. (1993) The effects of recombinant insulin-like growth factor I administration or growth hormone levels and insulin requirements in adolescents with type 1 insulin-dependent diabetes mellitus. Diabetologia 36 678.
293. AC Moses, SCJ Young, LA Morrow, et al. (1996) Recombinant human insulin-like growth factor I increases insulin sensitivity and improves glycemic control in Type II diabetes. Diabetes 45 95.
294. T Quattrin, K Thrailkill, L Baler, et al. (1997) Dual hormonal replacement with insulin and recombinant insulin like growth factor I in insulin dependent diabetes mellitus: effects on glycemic control, IGF-I levels, and safety profiles. Diabetes Care 20 374.
295. DR Clemmons, AC Moses, MJ McKay, et al. (2000) The combination of insulin-like growth factor I and insulin-like growth factor-binding protein-3 reduces insulin requirements in insulin-dependent type 1 diabetes: evidence for in vivo biological activity. J Clin Endocrinol Metab 85 1518.
296. DR Clemmons, M Sleevi, G Allan, et al. (2007) Effects of combined recombinant insulin-like growth factor (IGF)-I and IGF binding protein-3 in type 2 diabetic patients on glycemic control and distribution of IGF-I and IGF-II among serum binding protein complexes. J Clin Endocrinol Metab 92 2652.
297. RG Rosenfeld, A Belgorosky, C Camacho-Hubner, et al. (2007) Defects in growth hormone receptor signaling. Trends Endocrinol Metab 4 1043.
298. J Guevara-Aguirre, O Vasconez, V Martinez, et al. (1995) A randomized, double-blind, placebo-controlled trial of safety and efficacy of recombinant human insulin-like growth factor I in children with growth hormone receptor deficiency. J Clin Endocrinol Metab 80 1393.
299. PF Backeljaw and LE Underwood (1996) Prolonged treatment with recombinant insulin-like growth factor I in children with growth hormone insensitivity syndrome: a clinical research center study. J Clin Endocrinol Metab 81 3312.
300. SD Chernausek, PF Backeljauw, J Frane, et al. (2007) Long-term treatment with recombinant insulin-like growth factor (IGF)-I in children with severe IGF-I deficiency due to growth hormone insensitivity. J Clin Endocrinol Metab 92 902.
301. GM Keating (2008) Mecasermin. BioDrugs 22 177.
302. C Camacho-Hubner, KA Woods, F Miraki-Moud, et al. (1999) Effects of recombinant human insulin-like growth factor I (IGF-I) therapy on the growth hormone IGF system of a patient with partial IGF-I gene deletion. J Clin Endocrinol Metab 84 1611.
303. L de Lacerda, JA Carvalho, B Stannard, et al. (1999) In vitro and in vivo responses to short-term recombinant human insulin-like growth factor-1 (IGF-I) in a severely growth-retarded girl with ring chromosome 15 and deletion of a single allele for the type 1 IGF receptor gene. Clin Endocrinol 51 541.
304. Y Okubo, K Siddle, H Firth, et al. (2003) Cell proliferation activities on skin fibroblasts from a short child with absence of one copy of the type 1 insulin-like growth factor receptor (IGF1R) gene and a tall child with three copies of the IGF1R gene. J Clin Endocrinol Metab 88 5981.
305. MJ Abuzzahab, A Schneider, A Goddard, et al. (2003) IGF-I receptor mutations resulting in intrauterine and postnatal growth retardation. N Engl J Med 349 2211.